The June formulary updates include the addition of 38 new National Drug Codes (NDCs), representing 29 different prescription drugs, many with multiple strengths.
The formulary updates impact both stand-alone Medicare Part D plans (PDPs) and Medicare Advantage plans with drug coverage (MAPDs).
Highlights of the June 2021 Formulary update include six (6) newly-added brand-name drugs
The June drug data updates include 20 new brand-name drugs, six (6) of which are newly introduced brand-name drugs, some with multiple strengths. These drugs include:
- GEMTESA®,
- IMPAVIDO®,
- LUCEMYRA®,
- RELTONE®,
- UKONIQ®, and
- ZILXI®.
The June 2021 Formulary update includes five (5) newly-added generic drugs
The June Medicare Part D drug data also includes nine (9) new generic medications, five (5) of which are newly-introduced generic drugs. These new generic drugs include:
- ACCUTANE [ZENATANE®],
- ACETAMN-CAF-DIHYDRCODEIN [Trezix®],
- CYCLOPHOSPHAMIDE [Cytoxan®],
- DROXIDOPA [NORTHERA®], and
- ERYTHROMYCIN ES [E.E.S.®].
You can see our article "June 2021 Drug List Updates: Nine (9) new generic drugs added to many Medicare Part D plan formularies." found at on this site for more about coverage the new generics.
Please note that these new generic and brand-name drugs are not available on all Medicare Part D or Medicare Advantage drug plans - and you can review the chart to see the (often limited) number of plan formularies that now include these drugs.
Reminders about Medicare prescription drug plan formulary changes
- Medicare Part D plans (PDPs and MAPDs) can change their formulary or drug list during the year and may drop one of your formulary medication mid-year for specific Medicare-allowable reasons (such as a new generic drug is available), but there are steps you can take if your medication is no longer covered by your prescription drug plan.
- Your Medicare Part D plan
will notify you if the plan drops a medication you are currently using.
The NDC or National Drug Code is used to uniquely identify a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the drug manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging. You can read more on this site
Summary of June 2021 NDC changes
There are many reasons for NDCs to be added to the Medicare Part D program, a summary for all 38 new June 2021 NDCs is as follows:
| Reason for NDC Addition | Occurrences |
| New Delivery Form and Strength | 2 |
| New Drug | 16 |
| New Drug and Strength | 14 |
| New Manufacturer and Strength | 5 |
| New Strength | 1 |
| Grand Total | 38 |
The following chart details the 38 new manufacturer / drug-strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates -- as you will notices, some drugs are only covered by a few Medicare plans.
You can click on the Drug Name below to go to our on this site Drug Finder ( on this site) and see the details of how this drug is covered by all Medicare Part D plans (PDPs) in Florida (our example state). You can then change the state in our search form for details of drug coverage in your service area.
| NDC | Drug Name | Number of PDP Formularies* |
Number of MAPD Formularies* |
Notes |
| 72143023230 | ACCUTANE 20 MG CAPSULE [ZENATANE] | 56 | 332 | New Drug and Strength |
| 72143023330 | ACCUTANE 30 MG CAPSULE [ZENATANE] | 54 | 332 | New Drug and Strength |
| 72143023430 | ACCUTANE 40 MG CAPSULE [ZENATANE] | 56 | 332 | New Drug and Strength |
| 42195084010 | ACETAMN-CAF-DIHYDRCODEIN 320.5 CAPSULE [Trezix] | 5 | 33 | New Drug |
| 10019098209 | CYCLOPHOSPHAMIDE 25 MG TABLET [Cytoxan] | 57 | 351 | New Drug and Strength |
| 10019098409 | CYCLOPHOSPHAMIDE 50 MG TABLET [Cytoxan] | 57 | 351 | New Drug and Strength |
| 51862051403 | DESOGESTREL-EE 0.15-0.03 MG TABLET [Solia] | 59 | 346 | New Drug |
| 67877070490 | DROXIDOPA 100 MG CAPSULE [NORTHERA] | 67 | 389 | New Drug and Strength |
| 67877070590 | DROXIDOPA 200 MG CAPSULE [NORTHERA] | 67 | 389 | New Drug and Strength |
| 67877070690 | DROXIDOPA 300 MG CAPSULE [NORTHERA] | 67 | 389 | New Drug and Strength |
| 24338011003 | ERYTHROMYCIN ES 400 MG TABLET [E.E.S.] | 40 | 228 | New Drug |
| 00037044267 | FELBATOL 600 MG/5 ML ORAL SUSPENSION | 0 | 4 | New Delivery Form and Strength |
| 73336007530 | GEMTESA 75 MG TABLET | 3 | 27 | New Drug |
| 00548585000 | GLUCAGON 1 MG EMERGENCY KIT VIAL | 41 | 251 | New Drug |
| 52427080390 | GRALISE ER 300 MG TABLET ER 24H | 3 | 60 | New Drug and Strength |
| 52427080690 | GRALISE ER 600 MG TABLET ER 24H | 3 | 60 | New Drug and Strength |
| 43068030406 | HETLIOZ LQ 4 MG/ML ORAL SUSPENSION | 17 | 127 | New Delivery Form and Strength |
| 13107000401 | HYDROCODONE-IBUPROFEN 7.5-200 TABLET [Vicoprofen] | 51 | 358 | New Drug |
| 00078074303 | ILEVRO 0.3% OPHTH DROPS EYE DROPPER | 45 | 319 | New Drug |
| 51672417406 | IMIQUIMOD 3.75% CREAM PACK [Zyclara] | 3 | 83 | New Drug |
| 69051030001 | IMPAVIDO 50 MG CAPSULE | 32 | 195 | New Drug |
| 68180090373 | KAITLIB FE 0.8-0.025MG CHEWABLE TABLET [Layolis Fe] | 23 | 185 | New Drug |
| 78670005096 | LUCEMYRA 0.18 MG TABLET | 3 | 129 | New Drug |
| 00069031301 | MERREM IV 500 MG VIAL | 3 | 8 | New Drug |
| 42195030809 | NALFON 400 MG CAPSULE | 0 | 4 | New Strength |
| 52268030201 | NULYTELY SOLUTION RECON | 14 | 94 | New Drug |
| 00406051201 | OXYCODONE-ACETAMINOPHEN 5-325 TABLET [Roxicet] | 68 | 398 | New Drug |
| 00169413013 | OZEMPIC 1 MG/DOSE (4 MG/3 ML) PEN INJECTOR | 62 | 368 | New Manufacturer and Strength |
| 80056014301 | RELTONE 200 MG CAPSULE | 0 | 5 | New Drug and Strength |
| 80056014401 | RELTONE 400 MG CAPSULE | 0 | 5 | New Drug and Strength |
| 00006672268 | SINEMET 10-100 MG TABLET | 3 | 8 | New Manufacturer and Strength |
| 00006672468 | SINEMET 25-100 MG TABLET | 3 | 8 | New Manufacturer and Strength |
| 78670013102 | SYMJEPI 0.15 MG/0.3 ML SYRINGE | 18 | 233 | New Drug and Strength |
| 78670013002 | SYMJEPI 0.3 MG/0.3 ML SYRINGE | 18 | 234 | New Drug and Strength |
| 73150020012 | UKONIQ 200 MG TABLET | 68 | 398 | New Drug |
| 73562020810 | VIOKACE 20,880-78,300 UNIT TABLET | 11 | 50 | New Manufacturer and Strength |
| 73562011601 | ZENPEP DR 25,000 UNIT CAPSULE DR | 57 | 363 | New Manufacturer and Strength |
| 72356010303 | ZILXI 1.5% FOAM | 0 | 1 | New Drug |
You can review any Medicare plan formulary using the on this site Formulary Browser found at: FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your Service Area using our Drug Finder found at on this site.